F. Ann Millner - 03 Jun 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
03 Jun 2022
Net transactions value
-$206,926
Form type
4
Filing time
07 Jun 2022, 19:34:41 UTC
Previous filing
26 May 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $188,000 +10,000 +42% $18.80 34,076 03 Jun 2022 Direct
transaction MMSI Common Stock, No Par Value Sale $394,926 -6,378 -19% $61.92 27,698 03 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 03 Jun 2022 Common Stock 10,000 $18.80 Direct F2
holding MMSI Non-qualified stock options (right to buy) 20,000 03 Jun 2022 Common Stock 20,000 $34.40 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25,000 03 Jun 2022 Common Stock 25,000 $50.50 Direct F4
holding MMSI Non-qualified stock options (right to buy) 13,750 03 Jun 2022 Common Stock 13,750 $52.17 Direct F5
holding MMSI Non-qualified stock options (right to buy) 7,500 03 Jun 2022 Common Stock 7,500 $52.17 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.900 to $61.985, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
F3 Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F4 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F6 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.